Nanovibronix (NASDAQ:FEED) vs. Curaleaf (OTCMKTS:CURLF) Financial Contrast

Curaleaf (OTCMKTS:CURLF) and Nanovibronix (NASDAQ:FEED) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Valuation & Earnings

This table compares Curaleaf and Nanovibronix”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Curaleaf	$1.27 billion	2.00	-$231.07 million	($0.13)	-83.54
Nanovibronix	$1.93 million	0.21	-$18.18 million	($117.28)	-0.00

Nanovibronix has lower revenue, but higher earnings than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Curaleaf and Nanovibronix, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Curaleaf	0	0	2	3	3.60
Nanovibronix	1	0	0	0	1.00

Profitability

This table compares Curaleaf and Nanovibronix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Curaleaf	-2.62%	-0.88%	-0.26%
Nanovibronix	-1,093.61%	-60.73%	-48.48%

Insider and Institutional Ownership

0.0% of Curaleaf shares are held by institutional investors. Comparatively, 16.4% of Nanovibronix shares are held by institutional investors. 12.2% of Nanovibronix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Curaleaf has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.

Summary

Curaleaf beats Nanovibronix on 10 of the 14 factors compared between the two stocks.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.